Loading...

Amryt Pharma plc

AMYT•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$14.70
$0.00(0.00%)

Amryt Pharma plc (AMYT) Stock Overview

Explore Amryt Pharma plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 61.6/100

Key Financials

Market Cap0
P/E Ratio-38.16
EPS (TTM)$0.37
ROE-0.09%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$8.61

AMYT Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Amryt Pharma plc (AMYT) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $8.61.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -38.16 and a market capitalization of 0. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;